Updates from Prof. Arturo Casadevall

Back in May, Medical News Today spoke to Prof. Arturo Casadevall, from Johns Hopkins, about the potential of using convalescent plasma therapy in the treatment of COVID-19. Now, we follow up with Prof. Casadevall on the latest findings. In May, we spoke to Prof. Arturo Casadevall — chair of the Molecular Microbiology & Immunology Department […]

What will COVID-19 vaccine trials tell us? Less than some may think

What will COVID-19 vaccine candidate trials tell us? Not whether they will prevent deaths or serious illness, according to a new feature article in the BMJ. As the world looks to pharmaceutical companies to forge a way out of the COVID-19 pandemic, vaccine development...

10 new COVID-19 myths: Expert opinion

In this Special Feature, we asked our resident experts to chip away at some of the latest rumors, myths, and half-truths that surround the ongoing COVID-19 pandemic. All data and statistics are based on publicly available data at the time of publication. Some...

How does risk vary for Black and Asian patients with COVID-19?

New research suggests that people of Black, mixed, and Asian ethnicity are more at risk of COVID-19, but these risks vary as the disease progresses. A new study finds that COVID-19 risks for people of Black, mixed, or Asian ethnicity vary over the course of the...

Influenza drug shows promise against SARS-CoV-2

Researchers have found that high doses of a drug called favipiravir strongly inhibit SARS-CoV-2 in hamsters. Favipiravir also prevented infection in healthy animals that had exposure to an infected cage mate. It takes many years to develop a potent antiviral drug from...

1 in 3 excess deaths in the US not directly caused by COVID-19

Healthcare disruption and emotional crises may have led to around a third of the 225,530 “excess deaths” in the United States between March 1 and August 1, 2020, a new study suggests. The study, from researchers at the Virginia Commonwealth University School of...